Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.

On Monday, the FDA accepted Eisai Co., Ltd. (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) Biologics License Application (BLA) ...

Because Alzheimer’s is a progressive disease and these drugs do not affect underlying disease processes ... It does not provide medical advice, diagnosis or treatment. This content is not intended to ...

The approved drugs for Alzheimer’s disease do not address the underlying cause of the disease, but instead treat only the symptoms. However, there is a vast array of experimental treatments that are ...

A report questions the FDA's accelerated approval process citing Sarepta and Biogen therapies as examples. Read more here.